Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trial.
Holmberg-Thydén S, Dufva IH, Gang AO, Breinholt MF, Schejbel L, Andersen MK, Kadivar M, Svane IM, Grønbæk K, Hadrup SR, El Fassi D. Holmberg-Thydén S, et al. Among authors: svane im. Cancer Immunol Immunother. 2022 Feb;71(2):433-444. doi: 10.1007/s00262-021-02993-6. Epub 2021 Jul 4. Cancer Immunol Immunother. 2022. PMID: 34218294 Free PMC article. Clinical Trial.
Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers.
Svane IM, Pedersen AE, Johansen JS, Johnsen HE, Nielsen D, Kamby C, Ottesen S, Balslev E, Gaarsdal E, Nikolajsen K, Claesson MH. Svane IM, et al. Cancer Immunol Immunother. 2007 Sep;56(9):1485-99. doi: 10.1007/s00262-007-0293-4. Epub 2007 Feb 7. Cancer Immunol Immunother. 2007. PMID: 17285289 Free PMC article. Clinical Trial.
Cancer treatment: the combination of vaccination with other therapies.
Andersen MH, Sørensen RB, Schrama D, Svane IM, Becker JC, Thor Straten P. Andersen MH, et al. Among authors: svane im. Cancer Immunol Immunother. 2008 Nov;57(11):1735-43. doi: 10.1007/s00262-008-0480-y. Epub 2008 Feb 20. Cancer Immunol Immunother. 2008. PMID: 18286284 Free PMC article. Review.
RhoC a new target for therapeutic vaccination against metastatic cancer.
Wenandy L, Sørensen RB, Svane IM, Thor Straten P, Andersen MH. Wenandy L, et al. Among authors: svane im. Cancer Immunol Immunother. 2008 Dec;57(12):1871-8. doi: 10.1007/s00262-008-0517-2. Epub 2008 Apr 16. Cancer Immunol Immunother. 2008. PMID: 18415097 Free PMC article.
Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters.
Engell-Noerregaard L, Hansen TH, Andersen MH, Thor Straten P, Svane IM. Engell-Noerregaard L, et al. Among authors: svane im. Cancer Immunol Immunother. 2009 Jan;58(1):1-14. doi: 10.1007/s00262-008-0568-4. Epub 2008 Aug 22. Cancer Immunol Immunother. 2009. PMID: 18719915 Free PMC article. Review.
331 results